All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Innate Pharma SA, of Marseille, France, reported preclinical data for two of its programs. For its IPH33 program, it reported that humanized anti-TLR3 antibodies showed efficient blocking of TLR3 signaling with high potency.